Congress Passes New FDA Medical Devices User Fee Amendments (MDUFA V) Deal
The new deal provides the FDA a minimum of $1.78 billion in user fees from 2023 to 2027.
LDTs: Congress Set to Scuttle VALID Act at the Eleventh Hour
Congress reportedly set to pass a stripped-down version of the FDA user fees bill without the VALID Act component regulating LDTs.
Already a member? Log in here
New FDA Bill Bypasses LDTs Reform—Again
It now appears that Congress is going to dash the lab industry’s hopes yet again by reauthorizing FDA user fees without VALID.
House Passes Legislation to Better MA Prior Authorization Process
According to healthcare groups, the Improving Seniors’ Timely Access to Care Act would help fix problems with current system.
G2’s Lab Institute Returns in Virtual Format
This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.